Literature DB >> 8491094

The functional neuroanatomy of corticotropin-releasing factor.

P E Sawchenko1, T Imaki, E Potter, K Kovács, J Imaki, W Vale.   

Abstract

Descriptions of the central distribution of corticotropin-releasing factor (CRF) have been taken as generally supporting the proposition that this neuropeptide is involved in the mediation of complementary neuroendocrine, autonomic and behavioural responses to stress. The hypothalamic paraventricular nucleus (PVN) is recognized as the principal source of CRF in hypophysial portal plasma; CRF mRNA and peptide expression in parvocellular neurosecretory neurons are regulated negatively by adrenal steroids and positively by many stressors. Consistent with the latter, the hypophysiotropic zone of the PVN receives a rich, and biochemically differentiated, afferent supply that provides visceral, somatic and special sensory systems with access to the 'CRF neuron'. Within the PVN, CRF is also expressed, and differentially regulated, in oxytocinergic magnocellular neurosecretory neurons and in autonomic-related projection neurons. CRF expression in at least some extrahypothalamic cell groups (olfactory bulb, Barrington's nucleus) is responsive to certain stressful stimuli, but not to perturbations of the steroid environment. Refinement of our understanding of the central distribution of CRF has been provided by the recognition that most CRF antisera cross-react with an amidated dipeptide encoded by the melanin-concentrating hormone precursor, and by the likelihood that some central sites of CRF peptide expression may be muted or masked by the presence of a CRF-binding protein (CRF-BP). The CRF-BP is expressed prominently in the telencephalon, where it is co-localized with CRF in some neurons, and in anterior pituitary corticotrophs.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8491094     DOI: 10.1002/9780470514368.ch2

Source DB:  PubMed          Journal:  Ciba Found Symp        ISSN: 0300-5208


  53 in total

1.  Immunocytochemical distribution of corticotropin-releasing hormone receptor type-1 (CRF(1))-like immunoreactivity in the mouse brain: light microscopy analysis using an antibody directed against the C-terminus.

Authors:  Y Chen; K L Brunson; M B Müller; W Cariaga; T Z Baram
Journal:  J Comp Neurol       Date:  2000-05-08       Impact factor: 3.215

2.  Teneurin C-terminal associated peptide-1 blocks the effects of corticotropin-releasing factor on reinstatement of cocaine seeking and on cocaine-induced behavioural sensitization.

Authors:  David A Kupferschmidt; David A Lovejoy; Susan Rotzinger; Suzanne Erb
Journal:  Br J Pharmacol       Date:  2011-02       Impact factor: 8.739

Review 3.  Sex differences and stress across the lifespan.

Authors:  Tracy L Bale; C Neill Epperson
Journal:  Nat Neurosci       Date:  2015-09-25       Impact factor: 24.884

4.  CP-154,526, a CRF type-1 receptor antagonist, attenuates the cue-and methamphetamine-induced reinstatement of extinguished methamphetamine-seeking behavior in rats.

Authors:  M C Moffett; N E Goeders
Journal:  Psychopharmacology (Berl)       Date:  2006-11-21       Impact factor: 4.530

5.  Lamotrigine inhibits basal and Na+-stimulated, but not Ca2+-stimulated, release of corticotropin-releasing hormone from the rat hypothalamus.

Authors:  Giuseppe Tringali; Jean Michel Aubry; Pierluigi Navarra; Giacomo Pozzoli
Journal:  Psychopharmacology (Berl)       Date:  2006-09-01       Impact factor: 4.530

6.  Corticotropin releasing factor receptor type II (CRF2) messenger ribonucleic acid levels in the hypothalamic ventromedial nucleus of the infant rat are reduced by maternal deprivation.

Authors:  M Eghbal-Ahmadi; C G Hatalski; S Avishai-Eliner; T Z Baram
Journal:  Endocrinology       Date:  1997-11       Impact factor: 4.736

7.  Paraventricular nucleus corticotrophin releasing hormone contributes to sympathoexcitation via interaction with neurotransmitters in heart failure.

Authors:  Yu-Ming Kang; Ai-Qun Zhang; Xiu-Fang Zhao; Jeffrey P Cardinale; Carrie Elks; Xi-Mei Cao; Zhen-Wen Zhang; Joseph Francis
Journal:  Basic Res Cardiol       Date:  2011-02-02       Impact factor: 17.165

Review 8.  Stress is a principal factor that promotes tobacco use in females.

Authors:  Oscar V Torres; Laura E O'Dell
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2015-04-22       Impact factor: 5.067

9.  Type 1 corticotropin-releasing factor receptor expression reported in BAC transgenic mice: implications for reconciling ligand-receptor mismatch in the central corticotropin-releasing factor system.

Authors:  Nicholas J Justice; Zung Fan Yuan; Paul E Sawchenko; Wylie Vale
Journal:  J Comp Neurol       Date:  2008-12-01       Impact factor: 3.215

10.  Social stress and CRF-dopamine interactions in the VTA: role in long-term escalation of cocaine self-administration.

Authors:  Christopher O Boyson; Elizabeth N Holly; Akiko Shimamoto; Lucas Albrechet-Souza; Lindsay A Weiner; Joseph F DeBold; Klaus A Miczek
Journal:  J Neurosci       Date:  2014-05-07       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.